| Literature DB >> 19850081 |
Veenita Grover1, Margaret L Pierce, Peter Hoyt, Fengqiu Zhang, Ulrich Melcher.
Abstract
The potential of DNA microarrays for detection of plant viruses is hampered by underutilization of sequence-independent amplification methods for target nucleic acid enrichment. A microarray system is described for an unbiased detection of plant viruses using both short (30 nt) and long (50 and 70 nt) oligonucleotide probes. The assay involves amplification of target nucleic acid using random primers followed by in vitro transcription whose cRNA product is labeled chemically, fragmented and used as target for hybridization. Initial optimization tests with Turnip vein clearing virus and Cauliflower mosaic virus showed increased hybridization efficiency with shorter cDNA targets (100 bp) and longer probes (50 and 70 nt). The system was validated in pure and mixed samples by detection of three Tymovirus species: Asclepias asymptomatic virus, Kennedya yellow mosaic virus and Turnip yellow mosaic virus. The method could detect sequence variants with 70-75% or higher sequence identity, indicating the possible utility of the approach for virus discovery. Array performance comparison of long probes demonstrated the competence of 50-mers to provide a satisfactory balance between detection sensitivity and specificity. The work described is a significant step towards a method to assess, in one assay, the presence of a large diversity of relatives of known viruses of plants.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19850081 PMCID: PMC7112940 DOI: 10.1016/j.jviromet.2009.08.023
Source DB: PubMed Journal: J Virol Methods ISSN: 0166-0934 Impact factor: 2.014
Primer sequences used to amplify cDNA targets.
| Primer | Sequence 5′–3′ | Product size (bp) |
|---|---|---|
| TVCV100F | CAACCCAGGCGATGG | 100 |
| TVCV100R | AACTTTTCCCAGATCTTGTACTCTA | |
| TVCV300F | CACCAGAAAGACACCTGCGA | 300 |
| TVCV300R | GCAATGATGATGGTA | |
| TVCV1000F | CACCAGAAAGACACCTGCGA | 1000 |
| TVCV1000R | CTAGCCACTCTCCGG | |
| CaMV92F | ATGTCCACAAGGTCACT | 92 |
| CaMV92R | GAAATGCTTCGTCCAT | |
| CaMV307F | CGAGAAGCGAAGAGGAAAGAA | 307 |
| CaMV307R | TCTGAACACACGAAATGCTTC | |
Fig. 1Schematic outline of the strategy used to convert viral RNA and DNA into labeled cRNA for the microarray detection of viral sequences. The outline is abbreviated, with blocking and washing steps not depicted.
Sequences of DNA oligonucleotide target-specific probes used in the microarray.
| Probe | Target species/genus | Sequence 5′–3′ | Probe Length (nt) |
|---|---|---|---|
| 10000829 | GTCACTACGAATGGAATGTGGTCCCTTTCGGCTTAAAGCAAGCTCCATCCATATTCCAAAGACACATGGA | 70 | |
| 10000830 | TCCATGTGTCTTTGGAATATGGATGGAGCTTGCTTTAAGCCGAAAGGGACCACATTCCATTCGTAGTGAC | 70 | |
| 10003781 | AAATTCTGGAACTCGACATTTCGAAGTACGATAAGTCACAAAACGAGTTCCATTGTGCTGTAGAGTACAA | 70 | |
| 10003782 | TTGTACTCTACAGCACAATGGAACTCGTTTTGTGACTTATCGTACTTCGAAATGTCGAGTTCCAGAATTT | 70 | |
| Caulimoa.4734 | TGCCTTTTGGITTAAAGCAAGCGCC | 28 | |
| Tobamo I–III.4557 | CAGAATGAGTTTCATTGTGCWGTIGAGTAT | 30 | |
| TV3781-21 | GAGTTCCATTGTGCTGTAGAG | 21 | |
| TV3781-24 | GAGTTCCATTGTGCTGTAGAGTAC | 24 | |
| TV3781-27 | AACGAGTTCCATTGTGCTGTAGAGTAC | 27 | |
| TV3781-30 | CAAAACGAGTTCCATTGTGCTGTAGAGTAC | 30 | |
| TV3781-50 | GATAAGTCACAAAACGAGTTCCATTGTGCTGTAGAGTACAAGATCTGGGA | 50 | |
| (T20)-TV3781-30 | TTTTTTTTTTTTTTTTTTTTCAAAACGAGTTCCATTGTGCTGTAGAGTAC | 30 | |
| (TV3781-30)-T20 | CAAAACGAGTTCCATTGTGCTGTAGAGTACTTTTTTTTTTTTTTTTTTTT | 30 | |
| Acrypto2.66 | GACTGCTCTACCTCAACTTTTTACTTACT | 29 | |
| Acrypto2.66-T20 | GACTGCTCTACCTCAACTTTTTACTTACTTTTTTTTTTTTTTTTTTTT | 28 | |
| Furo1.773 | CTATCCATAGTATTTATGATATTG | 24 | |
| Furo1.773-T20 | CTATCCATAGTATTTATGATATTGTTTTTTTTTTTTTTTTTTTT | 24 | |
| Marafi.4636 | CCTGGAAAGCTTGCCAGACCCTCGCTCTCATGCACGATG | 39 | |
| Marafi.4636-T20 | CCTGGAAAGCTTGCCAGACCCTCGCTCTCATGCACGATGTTTTTTTTTTTTTTTTTTTT | 39 | |
| AAV1-T05P | GGTGAGGGGCCCACCTTCGACGCAAACACCGAGTTTTT | 33 | |
| AAV1-T10P | GGTGAGGGGCCCACCTTCGACGCAAACACCGAGTTTTTTTTTT | 33 | |
| AAV1-T20P | GGTGAGGGGCCCACCTTCGACGCAAACACCGAGTTTTTTTTTTTTTTTTTTTTT | 34 | |
| AAV1-T20M | CTCGGTGTTTGCGTCGAAGGTGGGCCCCTCACCTTTTTTTTTTTTTTTTTTTT | 34 | |
| Tymo.3202P (T) | Asclepias asymptomatic virus | AACATGAAAAATGGCTTCGATGGATTTTTTTTTTTTTTTTTTTT | 44 |
| Tymo.3202M (T) | Asclepias asymptomatic virus | TCCATCGAAGCCATTTTTCATGTTTTTTTTTTTTTTTTTTTT | 42 |
| Tymo.3202M (NT) | Asclepias asymptomatic virus | TCCATCGAAGCCATTTTTCATG | 22 |
| Tymo.5391P(T) | Asclepias asymptomatic virus | ACTTACGACGACAACACTGACTATAACTTTTTTTTTTTTTTTTTTTT | 47 |
| Tymo.5391M(T) | Asclepias asymptomatic virus | GTTATAGTCAGTGTTGTCGTCGTAAGTTTTTTTTTTTTTTTTTTTT | 46 |
| Tymo.5391M(NT) | Asclepias asymptomatic virus | GTTATAGTCAGTGTTGTCGTCGTAAG | 26 |
| Tymo.544P (T) | Asclepias asymptomatic virus | CATGCACGACGCTCTCATGTATTTTTTTTTTTTTTTTTTTT | 41 |
| Tymo.544M (T) | Asclepias asymptomatic virus | AATACATGAGAGCGTCGTGCATGTTTTTTTTTTTTTTTTTTTT | 43 |
| Tymo.544M (NT) | Asclepias asymptomatic virus | AATACATGAGAGCGTCGTGCATG | 23 |
| Tymo.829P (T) | Asclepias asymptomatic virus | TCCTGGAATCCTGGGGCCCCCTTTTTTTTTTTTTTTTTTTT | 41 |
| Tymo.829M (T) | Asclepias asymptomatic virus | GGGGGCCCCAGGATTCCAGGATTTTTTTTTTTTTTTTTTTT | 41 |
| Tymo.829M (NT) | Asclepias asymptomatic virus | GGGGGCCCCAGGATTCCAGGA | 21 |
| Tymotp.3295P (T) | Asclepias asymptomatic virus | AACATGAAAAATGGCTTCGATGGAATTCTCTTTTTTTTTTTTTTTTTTTTT | 51 |
| Tymotp.3295M (T) | Asclepias asymptomatic virus | GAGAATTCCATCGAAGCCATTTTTCATGTTTTTTTTTTTTTTTTTTTT | 48 |
| Tymotp.3295M (NT) | Asclepias asymptomatic virus | GAGAATTCCATCGAAGCCATTTTTCATG | 28 |
| Tymotp.4978P (T) | Asclepias asymptomatic virus | AACGACTATGCTCAGCTCTCCTCCAAAACCTTTTTTTTTTTTTTTTTTTTT | 51 |
| Tymotp.4978M (T) | Asclepias asymptomatic virus | GGTTTTGGAGGAGAGCTGAGCATAGTCGTTTTTTTTTTTTTTTTTTTT | 48 |
| Tymotp.4978M (NT) | Asclepias asymptomatic virus | GGTTTTGGAGGAGAGCTGAGCATAGTCG | 28 |
| Tymotp.5007P (T) | Asclepias asymptomatic virus | CAAATCCACCATTGTCGCCAATGCTTCCCGTTTTTTTTTTTTTTTTTTTTT | 51 |
| Tymotp.5007M (T) | Asclepias asymptomatic virus | CGGGAAGCATTGGCGACAATGGTGGATTTGTTTTTTTTTTTTTTTTTTTT | 50 |
| Tymotp.5007M (NT) | Asclepias asymptomatic virus | CGGGAAGCATTGGCGACAATGGTGGATTTG | 30 |
| Tymotp.5488P (T) | Asclepias asymptomatic virus | GGCACTTACGACGACAACACCGACTACAACTTTTTTTTTTTTTTTTTTTT | 51 |
| Tymotp.5488M (T) | Asclepias asymptomatic virus | GTTGTAGTCGGTGTTGTCGTCGTAAGTGCCTTTTTTTTTTTTTTTTTTTT | 50 |
| Tymotp.5488M (NT) | Asclepias asymptomatic virus | GTTGTAGTCGGTGTTGTCGTCGTAAGTGCC | 30 |
| Tymotp.5512P(T) | Asclepias asymptomatic virus | TACAACATTGCCGTGCTCTACTCTCAATACTTTTTTTTTTTTTTTTTTTTT | 51 |
| Tymotp.5512M(T) | Asclepias asymptomatic virus | GTATTGAGAGTAGAGCACGGCAATGTTGTATTTTTTTTTTTTTTTTTTTT | 50 |
| Tymotp.5512M(NT) | Asclepias asymptomatic virus | GTATTGAGAGTAGAGCACGGCAATGTTGTA | 30 |
| Tymotp.5725P (T) | Asclepias asymptomatic virus | CCTCGCTCTGTTCGCCAAGCTGATGATCGCTTTTTTTTTTTTTTTTTTTTT | 51 |
| Tymotp.5725M (T) | Asclepias asymptomatic virus | GCGATCATCAGCTTGGCGAACAGAGCGAGGTTTTTTTTTTTTTTTTTTTT | 50 |
| Tymotp.5725M (NT) | Asclepias asymptomatic virus | GCGATCATCAGCTTGGCGAACAGAGCGAGG | 30 |
| AsAV1_70P.1005 | Asclepias asymptomatic virus | CCTCTTCACCTACACAAGAGCGGTTCGAACCCTCCGAACCTCCGACCCCGCCGGCTTCGTTCGAACCCAG | 70 |
| AsAV1_70M.1074 | Asclepias asymptomatic virus | CTGGGTTCGAACGAAGCCGGCGGGGTCGGAGGTTCGGAGGGTTCGAACCGCTCTTGTGTAGGTGAAGAGG | 70 |
| AsAV1_50P.1010 | Asclepias asymptomatic virus | TCACCTACACAAGAGCGGTTCGAACCCTCCGAACCTCCGACCCCGCCGGC | 50 |
| AsAV1_50M.1059 | Asclepias asymptomatic virus | GCCGGCGGGGTCGGAGGTTCGGAGGGTTCGAACCGCTCTTGTGTAGGTGA | 50 |
| AsAV2_70P.3220 | Asclepias asymptomatic virus | CTTCAATCAGAAACTGAGAGACTCTCGCAATTCATCGACCACTATTGTTGGTGGACGTACAGAGTCCCAT | 70 |
| AsAV2_70M.3289 | Asclepias asymptomatic virus | ATGGGACTCTGTACGTCCACCAACAATAGTGGTCGATGAATTGCGAGAGTCTCTCAGTTTCTGATTGAAG | 70 |
| AsAV2_50P.3240 | Asclepias asymptomatic virus | ACTCTCGCAATTCATCGACCACTATTGTTGGTGGACGTACAGAGTCCCAT | 50 |
| AsAV2_50M.3289 | Asclepias asymptomatic virus | ATGGGACTCTGTACGTCCACCAACAATAGTGGTCGATGAATTGCGAGAGT | 50 |
| AsAV3 70P.4399 | Asclepias asymptomatic virus | TCCACCATCGTCGCCAATGCTTCCCGGTCTGACCCAGATTGGAGACATACTGCCGTCAAGATATTCGCCA | 70 |
| AsAV3_70M.4468 | Asclepias asymptomatic virus | TGGCGAATATCTTGACGGCAGTATGTCTCCAATCTGGGTCAGACCGGGAAGCATTGGCGACGATGGTGGA | 70 |
| AsAV3_50P.4407 | Asclepias asymptomatic virus | CGTCGCCAATGCTTCCCGGTCTGACCCAGATTGGAGACATACTGCCGTCA | 50 |
| AsAV3_50M.4456 | Asclepias asymptomatic virus | TGACGGCAGTATGTCTCCAATCTGGGTCAGACCGGGAAGCATTGGCGACG | 50 |
| AsAV4_70P.3129 | Asclepias asymptomatic virus | TTCCGACCCTTCCATTTCTCTCATCATCCTCCTTGGAGACCCTCTCCAGGGAGAGTATCATTCCACTTCC | 70 |
| AsAV4_70M.3198 | Asclepias asymptomatic virus | GGAAGTGGAATGATACTCTCCCTGGAGAGGGTCTCCAAGGAGGATGATGAGAGAAATGGAAGGGTCGGAA | 70 |
| AsAV4_50P.3149 | Asclepias asymptomatic virus | TCATCATCCTCCTTGGAGACCCTCTCCAGGGAGAGTATCATTCCACTTCC | 50 |
| AsAV4_50M.3198 | Asclepias asymptomatic virus | GGAAGTGGAATGATACTCTCCCTGGAGAGGGTCTCCAAGGAGGATGATGA | 50 |
| AsAV5_70P.4824 | Asclepias asymptomatic virus | CTCCACCCAATTCGGACCCCTCACCTGCATGCGCCTTACTGGAGAGCCCGGCACTTACGACGACAACACT | 70 |
| AsAV5_70M.4893 | Asclepias asymptomatic virus | AGTGTTGTCGTCGTAAGTGCCGGGCTCTCCAGTAAGGCGCATGCAGGTGAGGGGTCCGAATTGGGTGGAG | 70 |
| AsAV5_50P.4833 | Asclepias asymptomatic virus | ATTCGGACCCCTCACCTGCATGCGCCTTACTGGAGAGCCCGGCACTTACG | 50 |
| AsAV5_50M.4882 | Asclepias asymptomatic virus | CGTAAGTGCCGGGCTCTCCAGTAAGGCGCATGCAGGTGAGGGGTCCGAAT | 50 |
| KYMV1_70P.1012 | TCTCTTCACCTACACGCGAGCCGTCAGAACGCTCCGCGTCTCCGACCCCGCAGGCTTCGTTCGGACCCAA | 70 | |
| KYMV1_70M.1081 | TTGGGTCCGAACGAAGCCTGCGGGGTCGGAGACGCGGAGCGTTCTGACGGCTCGCGTGTAGGTGAAGAGA | 70 | |
| KYMV1_50P.1016 | TCACCTACACGCGAGCCGTCAGAACGCTCCGCGTCTCCGACCCCGCAGGC | 50 | |
| KYMV1_50M.1065 | GCCTGCGGGGTCGGAGACGCGGAGCGTTCTGACGGCTCGCGTGTAGGTGA | 50 | |
| KYMV2_70P.3425 | CTGCAGTCCGAGACCACCCGACTTCTCCCCTTCATTGATCACTACTGTTGGTGGACTTATCGTGTCCCCT | 70 | |
| KYMV2_70M.3494 | AGGGGACACGATAAGTCCACCAACAGTAGTGATCAATGAAGGGGAGAAGTCGGGTGGTCTCGGACTGCAG | 70 | |
| KYMV2_50P.3445 | ACTTCTCCCCTTCATTGATCACTACTGTTGGTGGACTTATCGTGTCCCCT | 50 | |
| KYMV2_50M.3494 | AGGGGACACGATAAGTCCACCAACAGTAGTGATCAATGAAGGGGAGAAGT | 50 | |
| KYMV3_70P.4594 | AACCCAAGCCACTCTCGTGGCCAACCACTCCCGTTCTGACCCCGACTGGCGCCACACAGCAGTCAAA | 67 | |
| KYMV3_70M.4660 | TTTGACTGCTGTGTGGCGCCAGTCGGGGTCAGAACGGGAGTGGTTGGCCACGAGAGTGGCTTGGGTT | 67 | |
| KYMV3_50P.4609 | CGTGGCCAACCACTCCCGTTCTGACCCCGACTGGCGCCACACAGCAGTCA | 50 | |
| KYMV3_50M.4658 | TGACTGCTGTGTGGCGCCAGTCGGGGTCAGAACGGGAGTGGTTGGCCACG | 50 | |
| KYMV4_70P.3334 | GGCAGACCCCTGTCTTGAACTGGTCATCATTCTCGGCGACCCTCTACAAGGCGAGTACCACTCCACTTCC | 70 | |
| KYMV4_70M.3403 | GGAAGTGGAGTGGTACTCGCCTTGTAGAGGGTCGCCGAGAATGATGACCAGTTCAAGACAGGGGTCTGCC | 70 | |
| KYMV4_50P.3354 | TGGTCATCATTCTCGGCGACCCTCTACAAGGCGAGTACCACTCCACTTCC | 50 | |
| KYMV4_50M.3403 | GGAAGTGGAGTGGTACTCGCCTTGTAGAGGGTCGCCGAGAATGATGACCA | 50 | |
| KYMV5_70P.5026 | TGCAACGCAGTTCGGCCCTCTGACCTGCATGCGCCTCACTGGCGAACCTGGCACCTACGACGACAACTCA | 70 | |
| KYMV5_70M.5095 | TGAGTTGTCGTCGTAGGTGCCAGGTTCGCCAGTGAGGCGCATGCAGGTCAGAGGGCCGAACTGCGTTGCA | 70 | |
| KYMV5_50P.5035 | GTTCGGCCCTCTGACCTGCATGCGCCTCACTGGCGAACCTGGCACCTACG | 50 | |
| KYMV5_50M.5084 | CGTAGGTGCCAGGTTCGCCAGTGAGGCGCATGCAGGTCAGAGGGCCGAAC | 50 | |
| TYMV1_70P.1033 | CCTGTTCACCTATACCAGAGCAGTCCGCACACTCCGAACTTCAGACCCAGCAGCATTCGTAAGGATGCAC | 70 | |
| TYMV1_70M.1102 | GTGCATCCTTACGAATGCTGCTGGGTCTGAAGTTCGGAGTGTGCGGACTGCTCTGGTATAGGTGAACAGG | 70 | |
| TYMV1_50P.1038 | TCACCTATACCAGAGCAGTCCGCACACTCCGAACTTCAGACCCAGCAGCA | 50 | |
| TYMV1_50M.1087 | TGCTGCTGGGTCTGAAGTTCGGAGTGTGCGGACTGCTCTGGTATAGGTGA | 50 | |
| TYMV2_70P.3356 | CTTCCCTCTGAAACTCTCAGGCTGCTACCATACATCGACATGTACTGCTGGTGGAGTTACCGCATTCCTC | 70 | |
| TYMV2_70M.3425 | GAGGAATGCGGTAACTCCACCAGCAGTACATGTCGATGTATGGTAGCAGCCTGAGAGTTTCAGAGGGAAG | 70 | |
| TYMV2_50P.3376 | GCTGCTACCATACATCGACATGTACTGCTGGTGGAGTTACCGCATTCCTC | 50 | |
| TYMV2_50M.3425 | GAGGAATGCGGTAACTCCACCAGCAGTACATGTCGATGTATGGTAGCAGC | 50 | |
| TYMV3_70P.4520 | TCCACCATAGTGGCCAACGCTTCACGCTCCGACCCAGACTGGCGACACACCACCGTCAAGATCTTCGCGA | 70 | |
| TYMV3_70M.4589 | TCGCGAAGATCTTGACGGTGGTGTGTCGCCAGTCTGGGTCGGAGCGTGAAGCGTTGGCCACTATGGTGGA | 70 | |
| TYMV3_50P.4528 | AGTGGCCAACGCTTCACGCTCCGACCCAGACTGGCGACACACCACCGTCA | 50 | |
| TYMV3_50M.4577 | TGACGGTGGTGTGTCGCCAGTCTGGGTCGGAGCGTGAAGCGTTGGCCACT | 50 | |
| TYMV4_70P.3265 | CGCCGACCCCGCCCTCGAGCTCGTCATAATTCTCGGCGATCCTCTMCAGGGCGAGTACCACTCCCAATCG | 70 | |
| TYMV4_70M.3334 | CGATTGGGAGTGGTACTCGCCCTGKAGAGGATCGCCGAGAATTATGACGAGCTCGAGGGCGGGGTCGGCG | 70 | |
| TYMV4_50P.3285 | TCGTCATAATTCTCGGCGATCCTCTMCAGGGCGAGTACCACTCCCAATCG | 50 | |
| TYMV4_50M.3334 | CGATTGGGAGTGGTACTCGCCCTGKAGAGGATCGCCGAGAATTATGACGA | 50 | |
| TYMV5_70P.4948 | CTCCACCCAGTTCGGCCCCCTCACATGCATGCGCCTAACCGGGGAACCCGGAACTTACGACGACAACACT | 70 | |
| TYMV5_70M.5017 | AGTGTTGTCGTCGTAAGTTCCGGGTTCCCCGGTTAGGCGCATGCATGTGAGGGGGCCGAACTGGGTGGAG | 70 | |
| TYMV5_50P.4957 | GTTCGGCCCCCTCACATGCATGCGCCTAACCGGGGAACCCGGAACTTACG | 50 | |
| TYMV5 50M.5006 | CGTAAGTTCCGGGTTCCCCGGTTAGGCGCATGCATGTGAGGGGGCCGAAC | 50 |
The table lists all the probes used in the study and described in the article.
70-mer probes for Turnip vein clearing virus and Cauliflower mosaic virus are probes described by Wang et al. (2003); M—minus-sense probe, P—plus-sense probe, (T)—tailed/spacer probe, (NT)—non-tailed/non-spacer probe. Probes not indicated as P or M are plus-sense probes.
Fig. 2TVCV and CaMV cDNA hybridization fluorescence intensity as a function of target and probe length. Signal patterns observed after microarray hybridization of (A) TVCV cDNA targets of three different lengths and (B) CaMV cDNA targets of two different lengths to a set of short and long TVCV- and CaMV-specific oligonucleotide probes. The long probes (10003781 and 10000830) are TVCV- and CaMV-specific perfect match 70-mer probes. Tobamo I–III 4557 and Caulimoa.4734 are short degenerate probes for TVCV and CaMV with five and two nucleotide mismatches, respectively. Error bars represent the standard deviations for analyzed probe replicates.
Fig. 3Signal patterns after hybridization of 100 and 300 bp cDNA targets of TVCV to six different length probes ranging from 21 to 70-mers for the same target. All six probes are sequence-specific perfect match probes. The suffix numbers of probes specify their length, for e.g. TV3781-21 is a 21 nt long probe. 10003781 is the long TVCV-specific 70-mer probe. Error bars represent the standard deviations for analyzed probe replicates.
Fig. 4Impact of spacers on hybridization efficiency of shorter probes. Hybridization of 100 and 300 bp TVCV cDNA targets to probes TV3781, T20-TV3781-30 and TV3781-30-T20 provided with no spacer, 5′-end T20 spacer and 3′-end T20 spacer, respectively. 10003781 is the long conserved TVCV-specific 70-mer probe. Hybridization of incoming targets to three target-irrelevant control probes (Marafi.4636, Acrypto2.66 and Furo1.773) with and without 3′-end spacers was also monitored to test for non-specific pairing of targets to spacers.
Fig. 5Signal patterns after microarray hybridization of labeled cRNA from (A) uninfected A. viridis used as a negative control and (B) AsAV infected A. viridis at 46 °C to a set of short target-specific and non-target probes (Table 2). Probe numbers 1–91 in both A and B are the non-tymoviral probes on the array ranging from 25 to 70-mers, whereas probe numbers 92–121 are the specific tymoviral probes. There are ten tymoviral probe sets in triplets, P(T), M(T), and M(NT) as shown in Table 2. P, M, T and NT stand for positive-sense, minus-sense, tailed/spacer and non-tailed/non-spacer-probes, respectively. The results for each triplet are presented in the same order, P(T), M(T), and M(NT), with M(T) probe showing the strongest signal in each set. The insert (C) shows the hybridization signal comparison between the AsAV-specific short probes with and without spacers. Only five of the ten with vs. without spacer probe comparisons are shown. Error bars represent the standard deviations for analyzed probe replicates.
Fig. 6Hybridization results of AsAV-, TYMV- and KYMV-infected samples as single infections or mixture. Uninfected A. viridis sample was a negative control target. The figure shows a composite overview of signal patterns in the form of a heat map for five individual hybridization reactions performed at (A) 60 °C and (B) 46 °C. Each column represents the signal intensities of the fifteen 50- or 70-mer species-specific oligonucleotide probes hybridized to the incoming viral targets.